readthroughSign in
CompanyFHTXNasdaqCambridge, MA

Foghorn Therapeutics Inc.

Foghorn Therapeutics discovers and develops medicines targeting chromatin regulatory system dependencies using its Gene Traffic Control platform.

10-QNov 9Latest SEC filing
Nov 9Latest story